VRTX

The 7 Best Biotech Stocks to Buy for February 2023

By Josh Enomoto, InvestorPlace Contributor
Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.

7 Cream-of-the-Crop Stocks to Buy Today

By Chris Lau, InvestorPlace Contributor
Fast-growing, underappreciated stocks to buy are trading at a steep discount and will reward investors as they rise in value.

3 Biotech Companies to Watch in 2023

By Muslim Farooque, InvestorPlace Contributor
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year.

7 Undervalued Biotech Stocks to Buy Before They Boom

By Josh Enomoto, InvestorPlace Contributor
While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy.

Our 7 Top Biotech Stock Picks for 2023

By Josh Enomoto, InvestorPlace Contributor
Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

7 Stocks on the Perfect 10 List

By Chris Lau, InvestorPlace Contributor
Companies that have strong quality, value, or growth grades are the stocks to buy once markets recognize their business potential.

These 7 Biotech Stocks Are Set to Boom in 2023

By Chris Markoch, InvestorPlace Contributor
This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

Why Is Crispr Therapeutics (CRSP) Stock Up Today?

By William White, InvestorPlace Writer
Crispr Therapeutics (CRSP) stock is gaining on Tuesday after the FDA granted exagamglogene autotemcel (exa-cel) a rolling review.

7 Growth Stocks to Buy During a Stock Market Crash

By Alex Sirois, InvestorPlace Contributor
A stock market crash will only strengthen the outlook of these companies, making them good growth stocks to buy.

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

By Samuel O'Brient, InvestorPlace Reporter
President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

5 Top Stocks Cathie Wood Is Selling This Week

By Eddie Pan, InvestorPlace Financial News Writer
Cathie Wood's ARKK received $54.2 million of inflows earlier this month, the most in a five-day period since May. Here's what she's selling.

4 Top Stock Trades for Monday: WMT, BAC, VRTX, COP

By Bret Kenwell, InvestorPlace Contributor
Walmart, Bank of America, Vertex Pharmaceuticals and ConocoPhillips were our top stock trades for Monday. Let's look at the charts now.

7 Cathie Wood Stocks That Are Worth Buying in March

By Tezcan Gecgil, InvestorPlace Contributor
Many Cathie Wood stocks have suffered losses over the past year, but these companies will likely see strong gains in the coming quarters.

3 Biotech Stocks That Could Boom or Bust in Q1

By Joel Baglole, InvestorPlace Contributor
The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future.

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In 

By Tezcan Gecgil, InvestorPlace Contributor
Covid-19 showed us how rapid advances in medicine and technology could create significant growth opportunities for healthcare stocks.

7 Best Biotech Stocks to Buy in 2021 with Huge Upside

By Alex Sirois, InvestorPlace Contributor
Biotech stocks are worth considering. Risk aside, big pharma firms can still produce big pharma returns at the end of the day.

7 Falling Knife Stocks To Sell Before Your Portfolio Bleeds Out

By Muslim Farooque, InvestorPlace Contributor
These seven falling knife stocks have been losing their values of-late and likely have a bumpy road ahead.

VRTX Stock: The Disappointing News Sending Vertex Pharma Shares Lower

By William White, InvestorPlace Writer
Vertex Pharma (VRTX) stock is dropping on Friday following the release of results from a Phase 2 clinical trial for VX-864.
Load More